Seeking Alpha

Endo Pharmaceuticals (ENDP -1.4%) slips on a downgrade to Hold at Cantor earlier today, citing a...

Endo Pharmaceuticals (ENDP -1.4%) slips on a downgrade to Hold at Cantor earlier today, citing a mediocre Q1 and saying it sees no reason to buy the stock ahead of the the pending Lidoderm settlement.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs